Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.

[1]  H. Rockette,et al.  Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. , 2010, The Journal of clinical investigation.

[2]  A. Quyyumi,et al.  Endothelial dysfunction and hypertension: cause or effect? , 2010, Hypertension.

[3]  R. Rubinshtein,et al.  Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. , 2010, European heart journal.

[4]  A. Quyyumi,et al.  Abstract 1723: Vitamin D Levels Are Associated With Exercise Capacity and Measures of Endothelial Function in Healthy Humans , 2009 .

[5]  M. Yūksel,et al.  Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. , 2009, The Journal of clinical endocrinology and metabolism.

[6]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[7]  K. Schechtman,et al.  1,25(OH)2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[8]  Takamitsu Nakamura,et al.  Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. , 2009, Journal of the American College of Cardiology.

[9]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[10]  D. Bruce,et al.  Failure of T cell homing, reduced CD4/CD8αα intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice , 2008, Proceedings of the National Academy of Sciences.

[11]  A. Levin,et al.  Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[12]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[13]  P. Vanhoutte,et al.  Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. , 2008, American journal of physiology. Heart and circulatory physiology.

[14]  Ramachandran S Vasan,et al.  Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study , 2008, Circulation.

[15]  J. Bernheim,et al.  Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. , 2008, American journal of physiology. Renal physiology.

[16]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[17]  M. Holick,et al.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. , 2008, The Journal of clinical endocrinology and metabolism.

[18]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[19]  P. Wilson,et al.  Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. , 2008, The American journal of clinical nutrition.

[20]  R. Vieth.  Vitamin D Toxicity, Policy, and Science , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  M. Sowers,et al.  Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. , 2007, American journal of hypertension.

[22]  Keith C. Norris,et al.  Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. , 2007, Archives of internal medicine.

[23]  Bess Dawson-Hughes,et al.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.

[24]  Edward Giovannucci,et al.  Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension , 2007, Hypertension.

[25]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.

[26]  H. Struijker‐Boudier,et al.  Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.

[27]  C. Treves,et al.  1,25‐Dihydroxyvitamin D3 inhibits tumor necrosis factor‐α‐induced adhesion molecule expression in endothelial cells , 2006 .

[28]  C. Treves,et al.  1,25-Dihydroxyvitamin D3 inhibits tumor necrosis factor-alpha-induced adhesion molecule expression in endothelial cells. , 2006, Cell biology international.

[29]  A. Pshezhetsky,et al.  Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor. , 2005, Biochemical and biophysical research communications.

[30]  M. Probst-Kepper,et al.  1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon-γ mediated macrophage activation , 2005 .

[31]  E. Lakatta,et al.  Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.

[32]  M. Probst-Kepper,et al.  D3 is a potent suppressor of interferon gamma-mediated macrophage activation , 2005 .

[33]  S. Pauen,et al.  Cause or Effect? , 2005, Psychiatric Quarterly.

[34]  E. Benjamin,et al.  Clinical Correlates and Heritability of Flow-Mediated Dilation in the Community: The Framingham Heart Study , 2004, Circulation.

[35]  Thomas Weber,et al.  Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery Disease , 2004, Circulation.

[36]  J. Shaw,et al.  Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.

[37]  A. Quyyumi.  Prognostic value of endothelial function. , 2003, The American journal of cardiology.

[38]  Claude Lenfant,et al.  Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. , 2003, Hypertension.

[39]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[40]  D. Wheeler,et al.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.

[41]  E. Benjamin,et al.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. , 2002, Journal of the American College of Cardiology.

[42]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[43]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[44]  D. Duprez,et al.  Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension. , 1994, Blood pressure.

[45]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.